Schemel Donald Robert 4
4 · Sun BioPharma, Inc. · Filed May 23, 2019
Insider Transaction Report
Form 4
Schemel Donald Robert
Director
Transactions
- Award
Stock Option (right to buy)
2019-05-21+6,800→ 6,800 totalExercise: $2.95Exp: 2029-05-21→ Common Stock (6,800 underlying) - Award
Stock Option (right to buy)
2019-05-21+27,000→ 27,000 totalExercise: $2.95Exp: 2029-05-21→ Common Stock (27,000 underlying)
Footnotes (2)
- [F1]Scheduled to become fully exercisable the day before the annual meeting of stockholders to be held in 2020.
- [F2]Immediately exercisable as to 50% of the shares and scheduled to vest with respect to 25% of the shares on each of May 21, 2020 and May 21, 2021.